Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Apolipoprotein E]

T Yamamura

    Nihon Rinsho. Japanese Journal of Clinical Medicine
    |December 1, 1994
    PubMed
    Summary
    This summary is machine-generated.

    Apolipoprotein E (apo E) genetic variations influence lipoprotein levels. Specific apo E variants, like E2 and E4, are linked to altered lipid profiles and increased risk of hyperlipoproteinemia and atherosclerosis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Second-look hepatectomy after 5FU arterial infusion in patients with primary unresectable hepatic colorectal metastases.

    International journal of oncology·2011
    Same author

    Search for diphoton events with large missing transverse energy in 7 TeV proton-proton collisions with the ATLAS detector.

    Physical review letters·2011
    Same author

    Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions.

    Physical review letters·2011
    Same author

    Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC.

    Physical review letters·2011
    Same author

    Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC.

    Physical review letters·2011
    Same author

    Molecular network of the comprehensive multiple sclerosis brain-lesion proteome.

    Multiple sclerosis (Houndmills, Basingstoke, England)·2009
    Same journal

    [Development of novel therapeutics for multiple myeloma and improvement of drug lag].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Clinical pharmacy services to patients of immunomodulatory drugs].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    Same journal

    [Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

    Nihon rinsho. Japanese journal of clinical medicine·2019
    See all related articles

    Area of Science:

    • Biochemistry
    • Genetics
    • Metabolic Disorders

    Context:

    • Apolipoprotein E (apo E) is crucial for lipoprotein metabolism, interacting with receptors to regulate lipid transport.
    • Genetic variations in apo E, specifically alleles epsilon 3, epsilon 2, and epsilon 4, result in distinct apo E isoforms (E3, E2, E4).
    • These isoforms exhibit differential binding affinities to lipoprotein receptors, impacting lipid clearance and plasma lipoprotein levels.

    Purpose:

    • To elucidate the role of apolipoprotein E genetic heterogeneity in lipoprotein metabolism.
    • To investigate the association between common apo E isoforms (E2, E3, E4) and plasma lipid profiles.
    • To explore the link between apo E variants and the development of hyperlipoproteinemia and atherosclerosis.

    Summary:

    • Apolipoprotein E (apo E) exhibits genetic diversity with three common alleles (epsilon 3, epsilon 2, epsilon 4) producing isoforms E3, E2, and E4.

    Related Experiment Videos

  • Apo E2 isoform shows defective receptor binding, leading to remnant accumulation and potentially Type III hyperlipoproteinemia in homozygotes.
  • Heterozygous individuals with E2 or E4 show altered lipid metabolism; E3/2 phenotype associates with reduced LDL and increased VLDL, while E4/3 associates with increased LDL.
  • Rare apo E mutants are also linked to hyperlipoproteinemia and atherosclerosis.

    • Impact:

    • Understanding apo E's role in lipid metabolism is vital for diagnosing and managing dyslipidemias.
    • Identifies specific apo E genotypes associated with increased cardiovascular risk, aiding in personalized medicine approaches.
    • Highlights the complex interplay of genetics and environment in the pathogenesis of hyperlipoproteinemia and atherosclerosis.